Health and Medicine
FDA Approves Merck's Lipfendra, First Oral Cholesterol Pill
FDA approves Merck's Lipfendra (enlicitide), the first oral PCSK9 inhibitor that lowers LDL cholesterol by up to 59%, far surpassing statins.
—5 min read
Tag
#Cholesterol
3 articles
HealthScience
Gene Therapy and Gamified Insurance Reshape Health Care
A single infusion of CRISPR gene therapy slashes cholesterol by 60%, while John Hancock gamifies health insurance with rewards for healthy habits.
—5 min read
HealthScience
CRISPR Gene Therapy Slashes Cholesterol in Early Trial
A single infusion of CRISPR therapy CTX310 reduced LDL cholesterol by nearly 50% in a Phase 1 trial, raising hopes for a one-time heart disease cure.
—5 min read